Skip to main content
. 2022 Aug 16;29(1):2685–2693. doi: 10.1080/10717544.2022.2111479

Figure 2.

Figure 2.

(A) XRD diagrams of raloxifene (blue), PSS (gray), HSA (green), and Ral/HSA/PSS NPs (red). (B) FTIR spectra of HSA (black), HSA/PSS (green) mixture, and Ral/HSA/PSS NPs (red).